Login to Your Account

Financings NEWS

Bioxcel Therapeutics Inc., a company using artificial intelligence to repurpose existing compounds for new uses, has filed to raise up to $69 million in an initial public offering intended to help it advance two candidates through proof of concept (POC), and possibly further.

Rani Therapeutics Inc., the San Jose, Calif.-based developer of a pill designed to replace injectable drugs for chronic disease, has raised $53 million to invest in manufacturing and preparation for clinical trials expected to begin within 12 months.

Xoc Pharmaceuticals Inc., a CNS-focused startup developing drugs for migraine prevention and Parkinson's disease (PD) maintenance, has closed a tranched $30 million series A financing led by New Enterprise Associates.

More Financings Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: